2 completed. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
Follow Staphylococcus Aureus Bacteremia: new trials by email Literature Review of Staphylococcus Aureus Bacteremia trials Research Report on Staphylococcus Aureus Bacteremia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia AP-SA02, Placebo - Bacteremia, Staphylococcus Aureus | Phase 1 / Phase 2 | Completed | Armata Pharmaceuticals, Inc. | 56 | 2022-04-26 | 2026-03-23 |
| Safety & Efficacy of True Human Antibody, 514G3, in Staphylococcus Aureus Bacteremia Hospitalized Subjects. 514G3 (2 mg/kg) plus standard IV antibiotic treatment, 514G3 (10 mg/kg) plus standard IV antibiotic treatment, 514G3 (40 mg/kg) plus standard IV antibiotic treatment - Staphylococcus Aureus Bacteremia | Phase 1 / Phase 2 | Completed | XBiotech, Inc. | 52 | 2015-05-01 | 2026-02-09 |
Bacteremia (2) · Staphylococcal Infections (2)
Bacterial Infections (2) · Bacterial Infections and Mycoses (2) · Gram-Positive Bacterial Infections (2) · Infections (2) · Inflammation (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Sepsis (2) · Systemic Inflammatory Response Syndrome (2)
Armata Pharmaceuticals, Inc. (1) · XBiotech, Inc. (1)
United States (2) · Australia (1)
Deborah Birx, MD (1) · Mark Rupp, M.D. (1)